Reducing cardiovascular risk in diabetes: Beyond glycemic and blood pressure control
- 1 June 2006
- journal article
- review article
- Published by Elsevier in International Journal of Cardiology
- Vol. 110 (2) , 137-145
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Global Prevalence of DiabetesDiabetes Care, 2004
- European guidelines on cardiovascular disease prevention in clinical practiceAtherosclerosis, 2003
- MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trialThe Lancet, 2003
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialThe Lancet, 2003
- The UKPDS: implications for the dyslipidaemic patientActa Diabetologica, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Diabetes and Decline in Heart Disease Mortality in US AdultsJAMA, 1999
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998